The circadian gene CHRONO drives hepatocellular carcinoma proliferation via G1/S cell cycle transition

Mar 19, 2026Biochemical and biophysical research communications

The daily rhythm gene CHRONO may promote liver cancer growth by speeding up cell division

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗

Abstract

CHRONO expression is elevated across multiple malignancies, with high levels in hepatocellular carcinoma (HCC) significantly correlating with poorer prognosis.

Dysregulation of clock genes is linked to cancer malignancy.
Inhibiting aberrantly expressed clock genes can suppress cancer cell growth.
Knocking down CHRONO in hepatocarcinoma cells significantly inhibits cell proliferation.
Suppression of CHRONO leads to G1-phase cell cycle arrest by reducing key regulators.
CHRONO may represent a safer therapeutic target due to its unique function without disrupting circadian rhythms.

AI simplified

Clock genes are essential for physiological homeostasis, and their dysregulation is closely linked to cancer malignancy. While inhibiting aberrantly expressed clock genes can suppress cancer cell proliferation, targeting core clock components often disrupts the fundamental circadian oscillatory system, posing potential risks to systemic physiology. CHRONO, a recently identified clock gene, functions as a unique transcriptional repressor whose deletion does not impair circadian oscillations, suggesting that it may represent a safer therapeutic target. In this study, we elucidated the clinical and pathological significance of CHRONO in cancer. Pan-cancer database analyses revealed that CHRONO expression is elevated across multiple malignancies; notably, in hepatocellular carcinoma (HCC), high CHRONO expression significantly correlates with poorer prognosis. Consistent with these findings, functional assays in human and murine hepatocarcinoma cells demonstrated that Chrono knockdown markedly inhibits cell proliferation. Mechanistically, suppression of CHRONO induced G1-phase arrest by decreasing the protein expression of key cell cycle regulators, including cyclin D and cyclin E. Collectively, our findings provide the first functional evidence that CHRONO acts as a pro-proliferative regulator in HCC, suggesting that modulation of CHRONO may suppress tumor growth while minimizing disruption of the core circadian oscillator.

Full Text

Full text is available at the source.

View full text (XML) ↗View full text ↗

The circadian gene CHRONO drives hepatocellular carcinoma proliferation via G1/S cell cycle transition

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief